4041 - 4050 of 7916 Results
Title
Year
-
OPENTitle: Incidence and risk factors for seizures associated with deep brain stimulation surgeryJournal Name: Journal of NeurosurgeryPublisher: Journal of Neurosurgery Publishing Group (JNSPG)Vol: 135Issue #: 1Start Page: 279End Page: 283Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3171/2020.5.jns20125Best OA location URL: https://thejns.org/downloadpdf/journals/j-neurosurg/135/1/article-p279.pdfCitation Count: 14
-
RESTRICTEDTitle: Infusion Therapies for Parkinson’s DiseaseJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-020-01062-2Citation Count: 12
- Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers2020OPENTitle: Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 57End Page: 63Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.033Best OA location URL: http://www.prd-journal.com/article/S1353802020301504/pdfCitation Count: 20
- Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review2020RESTRICTEDTitle: Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic reviewJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 415Issue #:Start Page: 116886End Page: 116886Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.116886Best OA location URL: https://discovery.ucl.ac.uk/10102806/1/Rizig_Revised%20MS%20-%20Clean%20Version.pdfCitation Count: 16
-
OPENTitle: Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 78Issue #:Start Page: 138End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.07.022Best OA location URL: http://manuscript.elsevier.com/S1353802020306593/pdf/S1353802020306593.pdfCitation Count: 15
- The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders2020RESTRICTEDTitle: The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological DisordersJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 8Start Page: 927End Page: 927Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.1452Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/226023/226023.pdfCitation Count: 183
-
OPENTitle: The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 163End Page: 169Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.027Best OA location URL: http://spiral.imperial.ac.uk/bitstream/10044/1/68972/2/WilsonPolitis_PDE4_SleepPD_RevisedText_Clean.pdfCitation Count: 14
-
RESTRICTEDTitle: The UPRosome – decoding novel biological outputs of IRE1α functionJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 133Issue #: 15Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1242/jcs.218107Best OA location URL: https://journals.biologists.com/jcs/article-pdf/133/15/jcs218107/1987768/jcs218107.pdfCitation Count: 38
- Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study2020OPENTitle: Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 8Start Page: e038911End Page: e038911Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/bmjopen-2020-038911Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/8/e038911.full.pdfCitation Count: 24
-
OPENTitle: Cortical disinhibition in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 11Start Page: 3408End Page: 3421Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa274Best OA location URL: https://academic.oup.com/brain/article-pdf/143/11/3408/36134872/awaa274.pdfCitation Count: 54